Xeris Pharmaceuticals | XERS - Trade Creditors

Stock Price
5.43
Daily Change
-0.18 -3.21%
Monthly
-19.32%
Yearly
-1.45%
Q1 Forecast
5.30

Xeris Pharmaceuticals reported $6.53M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Celltrion KRW 104.19B 15.67B Sep/2025
Cspc Pharmaceutical CNY 2.09B 42.45M Jun/2025
Deva Holding AS TRY 809.81M 105.88M Sep/2023
Dianthus Therapeutics USD 9.72M 3.02M Dec/2025
Divis Laboratories Ltd INR 10.4B 1.3B Sep/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Kangmei Pharma CNY 2.61B 176.42M Sep/2025
Knight Therapeutics CAD 118.13M 8.16M Sep/2025
Laboratorios Farma EUR 107.59M 341K Dec/2023
Malin Corporation EUR 700K 200K Dec/2024
Medical Developments International AUD 4.31M 2.18M Dec/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Neuren Pharmaceuticals AUD 2.4M 4.26M Dec/2025
Organigram Holdings CAD 89.25M 556K Sep/2025
Ovoca Bio EUR 209K 242K Dec/2024
Pacira USD 15.15M 2.54M Dec/2025
Perrigo USD 474.5M 4.8M Dec/2025
Pharma Mar EUR 54.34M 10.54M Dec/2025
Qiagen NV USD 72.66M 2.11M Dec/2025
Sartorius EUR 323.2M 61M Sep/2025
Sino Biopharmaceutical CNY 2.82B 1.32B Jun/2025
Supernus Pharmaceuticals USD 107.8M 813K Dec/2025
Tilray USD 107.35M 8.43M Mar/2025
Zz Pientze Pharmaceu CNY 516.14M 31.53M Sep/2025